Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 13,767 | 11,488 | 12,779 | 14,311 | 11,977 |
| Operating Income | -13,767 | -11,488 | -12,779 | -14,311 | -11,977 |
| Other Income | -179 | -145 | -96 | -138 | 60 |
| Pre-tax Income | -13,946 | -11,633 | -12,875 | -14,449 | -11,917 |
| Net Income Continuous | -13,946 | -11,633 | -12,875 | -14,449 | -11,917 |
| Net Income | $-13,946 | $-11,633 | $-12,875 | $-14,449 | $-11,917 |
| EPS Basic Total Ops | -14.00 | -11.60 | -12.80 | -16.00 | -13.20 |
| EPS Basic Continuous Ops | -13.92 | -11.36 | -12.89 | -15.93 | -13.27 |
| EPS Diluted Total Ops | -14.00 | -11.60 | -12.80 | -16.00 | -13.20 |
| EPS Diluted Continuous Ops | -13.92 | -11.36 | -12.89 | -15.93 | -13.27 |
| EBITDA(a) | $-13,496 | $-11,263 | $-12,617 | $-14,138 | $-11,744 |